Soho Global Health Tbk PT
IDX:SOHO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
458
765
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Soho Global Health Tbk PT
Soho Global Health Tbk PT
Total Receivables
Soho Global Health Tbk PT
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Total Receivables
Rp1.7T
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Total Receivables
Rp1.7T
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Total Receivables
Rp5.7T
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Total Receivables
Rp724B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Total Receivables
Rp617.5B
|
CAGR 3-Years
85%
|
CAGR 5-Years
68%
|
CAGR 10-Years
33%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Total Receivables
Rp2.3T
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
12%
|
|
Soho Global Health Tbk PT
Glance View
PT SOHO Global Health engages in the provision of healthcare services. The company is headquartered in Jakarta, Dki Jakarta and currently employs 2,373 full-time employees. The company went IPO on 2020-09-08. The firm operates through five segments: Distribution, Professional product, Consumer health, Alliance and Others. Its brands include Curcuma Plus, Curcuma Plus Milk, Imboost, Fitkom, Diapet, Laxing, Lelap, Asthma Soho and Sohobion. Curcuma Plus is a kid’s multivitamin that contains curcuma and fish oil. Curcuma Plus Milk is a growing up milk for kids. Imboost is a supplement that supports immune system. Fitkom offers kids multivitamins in gummy and tablet format. Diapet is an anti-diarrheal medicine. Laxing is a medicine for healthy digestion and bowel movement. Lelap is a medicine to alleviate sleep disorders. Asthma Soho is an asthma remedy. Sohobion is a neurotropic vitamin supplement to maintain neurological health. Its product portfolio ranged from wound care, hospital general care, surgery, orthopedics and in-vitro diagnostics.
See Also
What is Soho Global Health Tbk PT's Total Receivables?
Total Receivables
1.7T
IDR
Based on the financial report for Dec 31, 2023, Soho Global Health Tbk PT's Total Receivables amounts to 1.7T IDR.
What is Soho Global Health Tbk PT's Total Receivables growth rate?
Total Receivables CAGR 5Y
13%
Over the last year, the Total Receivables growth was 20%. The average annual Total Receivables growth rates for Soho Global Health Tbk PT have been 10% over the past three years , 13% over the past five years .
You don't have any saved screeners yet
